Westfield restructure: What investors need to know

Will the Westfield restructure get over the line?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Lowy family's proposal to restructure Westfield Group (ASX: WDC) and Westfield Retail Trust (ASX: WRT) comes to a head today, with a series of investor meetings.

Based on media reports though, the proposal could be defeated, with more than 20% of shareholders understood to have voted against the deal already. The Lowy family needs 75% of shareholders to vote for the deal, for it to go ahead.

If you aren't sure what is happening in the restructure here's the details…

  • Westfield Group currently jointly owns the group's Australian and New Zealand property assets with the Retail Trust. The proposal will see all these Australasian assets combined to form a new company called Scentre Group.
  • Westfield Group will take over the group's international operations, and be known as Westfield Corporation.

While that makes plenty of sense, many shareholders are opposed to the deal, including the Australian Shareholders Association (ASA). The ASA says the Lowy family's decision to sell its $665 million stake in the Retail Trust just a few months ago, a unfair deal for Retail Trust shareholders, and an almost doubling of the debt ratio from 22.4% of assets to 37.3% of assets in Scentre, make the deal unpalatable for Retail Trust shareholders.

John Durie, in The Australian, writes that the deal is being done for family rather than economically rational reasons, and says debt in Scentre will rise from $2.9 billion to $12.2 billion, while assets will increase from $13.7 billion to $28.6 billion.

The ASA is also concerned that Westfield is paying investment banks a combined $70 million to advise on the deal, and the new Scentre group will be a more riskier proposition than the Retail Trust – not to mention that the restructure will cost Westfield shareholders $520 million.

The Lowy's may have realised the terms of the restructure was unfair, and have reduced the net debt in Scentre Group by $300 million (after two independent advisors and two proxy advisors had supported the plan).

The vote will probably go down to the wire today, but it would be a big blow for the Lowys if the deal was defeated.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »